Search by Drug Name or NDC

    NDC 61990-0611-02 tranexamic acid 100 mg/mL Details

    tranexamic acid 100 mg/mL

    tranexamic acid is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apollo Pharmaceuticals Inc.. The primary component is TRANEXAMIC ACID.

    Product Information

    NDC 61990-0611
    Product ID 61990-0611_91881d51-b73e-4bbe-9cf5-9b5f213e7db9
    Associated GPIs 84100040002025
    GCN Sequence Number 068183
    GCN Sequence Number Description tranexamic acid VIAL 1000 MG/10 INTRAVEN
    HIC3 M9D
    HIC3 Description ANTIFIBRINOLYTIC AGENTS
    GCN 30912
    HICL Sequence Number 002802
    HICL Sequence Number Description TRANEXAMIC ACID
    Brand/Generic Generic
    Proprietary Name tranexamic acid
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tranexamic Acid
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name TRANEXAMIC ACID
    Labeler Name Apollo Pharmaceuticals Inc.
    Pharmaceutical Class Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212676
    Listing Certified Through n/a

    Package

    NDC 61990-0611-02 (61990061102)

    NDC Package Code 61990-0611-2
    Billing NDC 61990061102
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (61990-0611-2) / 10 mL in 1 VIAL, SINGLE-DOSE (61990-0611-0)
    Marketing Start Date 2019-09-30
    NDC Exclude Flag N
    Pricing Information N/A